Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Anlon Healthcare Ltd (AHCL) Share Price & Fundamentals

Company Overview

Founded Year

2013

Listed Year

2025

Headquarter

Rajkot, Gujarat, India

MD/CEO

-

Website

-

Company Facts

What we do

Anlon Healthcare Ltd manufactures pharmaceutical intermediates and active pharmaceutical ingredients, including loxoprofen sodium dihydrate, serving pain and inflammation treatment markets.

Founded in

2,013

Market share

Among few Indian manufacturers of loxoprofen sodium dihydrate, catering to domestic and export markets.

Problem solved

Provides key pharmaceutical raw materials for effective treatment of pain, inflammation, and related health conditions.

Top clients or who we serve

Pharmaceutical formulation companies producing tablets, capsules, ointments, nutraceuticals, personal care, and animal health products; B2B focused.

Key management

-

Our journey and innovations

Incorporated in 2013, commenced commercial production in 2018, expanded into custom manufacturing of complex chemical compounds recently.

Where we operate

Primarily India (Rajkot plant) with domestic and export sales markets.

Top products or what we offer

Pharma intermediates and APIs focusing on loxoprofen sodium dihydrate and custom chemical manufacturing services.

Top brands

Loxoprofen Sodium Dihydrate API - key product; customized chemical compounds for pharmaceutical clients.

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily recurring from continuous pharmaceutical API supply contracts.

Our industry position

Niche manufacturer in pharmaceutical intermediates with expanding footprint and product portfolio.

Financial highlights

FY 2024-25 revenue of Rs 120.29 Cr with net profit of Rs 20.52 Cr, reflecting solid profitability.

Geographical revenue split

Domestic sales Rs 116.39 Cr; exports Rs 3.90 Cr in FY 2024-25.

Order book

-

Whats driving growth

Growing pharmaceutical demand, custom synthesis capabilities, and improved production capacity.

Our future plans

Expanding manufacturing capacity and product offerings to address complex APIs and custom manufacturing.

Our green promise

-

Our people and values

-

Key challenges ahead

Competition from larger API manufacturers and regulatory compliance complexities.

Interesting facts

Among few Indian producers of loxoprofen sodium dihydrate, a key pain management API.

Risks and strategy

Mitigating supply chain and regulatory risks via diversification and quality certifications.

Market Footprint

Top Clients

Top Clients

Pharmaceutical formulation companies producing tablets, capsules, ointments, nutraceuticals, personal care, and animal health products; B2B focused.

Top Products

Top Products

Pharma intermediates and APIs focusing on loxoprofen sodium dihydrate and custom chemical manufacturing services.

Price Movement & Share Holding

Today's High/Low

23.9425.4

52 Week High/Low

10.3737.24
Past Returns

1 week

-4.53%

1 month

-29.4%

3 month

56.56%

1 year

-80.26%

3 year

-73.32%

5 year

-73.32%

Share Holding

Promoters

52.68%

FII

1%

DII

0.3%

Retail

31.2%

Others

14.82%

Company Overview

Founded Year

2013

Listed Year

2025

Headquarter

Rajkot, Gujarat, India

MD/CEO

-

Website

-

Price Movement & Share Holding

Today's High/Low

23.9425.4

52 Week High/Low

10.3737.24

Past Returns

1 week

-4.53%

1 month

-29.4%

3 month

56.56%

1 year

-80.26%

3 year

-73.32%

5 year

-73.32%

Share Holding

Promoters

52.68%

FII

1%

DII

0.3%

Retail

31.2%

Others

14.82%

Company Facts

What we do

Anlon Healthcare Ltd manufactures pharmaceutical intermediates and active pharmaceutical ingredients, including loxoprofen sodium dihydrate, serving pain and inflammation treatment markets.

Founded in

2013

Market share

Among few Indian manufacturers of loxoprofen sodium dihydrate, catering to domestic and export markets.

Problem solved

Provides key pharmaceutical raw materials for effective treatment of pain, inflammation, and related health conditions.

Top clients or who we serve

Pharmaceutical formulation companies producing tablets, capsules, ointments, nutraceuticals, personal care, and animal health products; B2B focused.

Our journey and innovations

Incorporated in 2013, commenced commercial production in 2018, expanded into custom manufacturing of complex chemical compounds recently.

Where we operate

Primarily India (Rajkot plant) with domestic and export sales markets.

Top products or what we offer

Pharma intermediates and APIs focusing on loxoprofen sodium dihydrate and custom chemical manufacturing services.

Top brands

Loxoprofen Sodium Dihydrate API - key product; customized chemical compounds for pharmaceutical clients.

Recurring vs cyclical contribution

Revenue primarily recurring from continuous pharmaceutical API supply contracts.

Our industry position

Niche manufacturer in pharmaceutical intermediates with expanding footprint and product portfolio.

Financial highlights

FY 2024-25 revenue of Rs 120.29 Cr with net profit of Rs 20.52 Cr, reflecting solid profitability.

Geographical revenue split

Domestic sales Rs 116.39 Cr; exports Rs 3.90 Cr in FY 2024-25.

Whats driving growth

Growing pharmaceutical demand, custom synthesis capabilities, and improved production capacity.

Our future plans

Expanding manufacturing capacity and product offerings to address complex APIs and custom manufacturing.

Key challenges ahead

Competition from larger API manufacturers and regulatory compliance complexities.

Interesting facts

Among few Indian producers of loxoprofen sodium dihydrate, a key pain management API.

Risks and strategy

Mitigating supply chain and regulatory risks via diversification and quality certifications.

Market Footprint

Top Clients

Top Clients

Pharmaceutical formulation companies producing tablets, capsules, ointments, nutraceuticals, personal care, and animal health products; B2B focused.

Top Products

Top Products

Pharma intermediates and APIs focusing on loxoprofen sodium dihydrate and custom chemical manufacturing services.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions